| 摘要 |
The present invention provides compositions and methods for reducing plasma Lp(a) levels in human. The present invention provides compositions and methods for reducing the risk factors for cardiovascular diseases. Moreover, this invention provides therapeutic alternatives to current pharmaceutical interventions for the reducing of cholesterol, LDL-cholesterol, triglycerides and other metabolic risk factors.
|
